Heregulin controls ERα and HER2 signaling in mammospheres of ERα-positive breast cancer cells and interferes with the efficacy of molecular targeted therapy

Publication date: Available online 11 May 2020Source: The Journal of Steroid Biochemistry and Molecular BiologyAuthor(s): Fumiyo Fukui, Shin-ichi Hayashi, Yuri Yamaguchi

Source: The Journal of Steroid Biochemistry and Molecular Biology - May 12, 2020 Category: Biochemistry Source Type: research